Page last updated: 2024-09-05

sb 203580 and apicularen b

sb 203580 has been researched along with apicularen b in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(apicularen b)
Trials
(apicularen b)
Recent Studies (post-2010) (apicularen b)
3,48941,137800

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahn, JW; Hong, J; Ishihara, K; Ohuchi, K; Yamaki, K; Zee, O1

Other Studies

1 other study(ies) available for sb 203580 and apicularen b

ArticleYear
Induction of apoptosis of RAW 264.7 cells by the cytostatic macrolide apicularen A.
    The Journal of pharmacy and pharmacology, 2003, Volume: 55, Issue:9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Caspases; Cell Line; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; G1 Phase; Imidazoles; Macrolides; Macrophages; Mice; Molecular Structure; Organic Chemicals; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines

2003